Profile data is unavailable for this security.
About the company
COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. It also provides tobacco and others.
- Revenue in JPY (TTM)936.71bn
- Net income in JPY24.87bn
- Incorporated1983
- Employees5.29k
- LocationCosmos Pharmaceutical Corp4F, S Kan, Daiichi Fukuoka Bldg.2-10-1, Hakataeki HigashiHakata-kuFUKUOKA-SHI 812-0013JapanJPN
- Phone+81 924330660
- Websitehttps://www.cosmospc.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AIN Holdings Inc | 391.20bn | 11.34bn | 220.40bn | 10.65k | 19.28 | 1.64 | 10.08 | 0.5634 | 322.68 | 322.68 | 11,135.34 | 3,791.57 | 1.65 | 13.17 | 30.96 | 36,728,570.00 | 4.79 | 4.10 | 8.12 | 6.66 | 14.63 | 15.71 | 2.90 | 2.68 | 0.7907 | -- | 0.04 | 23.97 | 13.44 | 5.98 | 30.20 | -2.66 | 26.79 | 3.71 |
| Create SD Holdings Co Ltd | 411.72bn | 13.90bn | 227.85bn | 4.73k | 15.94 | 1.73 | 12.17 | 0.5534 | 213.90 | 213.90 | 6,326.44 | 1,970.86 | 2.14 | 8.10 | 32.18 | 87,025,370.00 | 7.22 | 7.62 | 10.85 | 12.11 | 26.28 | 27.44 | 3.38 | 3.57 | 0.8374 | -- | 0.00 | 23.01 | 8.62 | 7.27 | 2.62 | 6.26 | 19.37 | 8.87 |
| Kusuri No Aoki Holdings Co Ltd | 423.36bn | 8.64bn | 273.34bn | 4.46k | 31.65 | 2.43 | 12.82 | 0.6457 | 91.29 | 91.29 | 4,475.41 | 1,191.11 | 1.56 | 7.00 | 42.38 | 94,923,100.00 | 3.18 | 6.14 | 4.60 | 9.49 | 27.35 | 28.26 | 2.04 | 3.66 | 0.7704 | 65.45 | 0.4247 | 6.37 | 15.39 | 11.35 | 25.28 | 6.92 | 7.90 | 12.63 |
| Sugi Holdings Co Ltd | 744.48bn | 21.98bn | 443.25bn | 7.73k | 19.21 | 1.81 | 12.28 | 0.5954 | 121.46 | 121.46 | 4,114.16 | 1,289.59 | 2.01 | 6.52 | 18.18 | -- | 5.92 | 6.11 | 8.99 | 9.30 | 30.74 | 30.38 | 2.95 | 3.21 | 0.8443 | -- | 0.0036 | 23.94 | 11.51 | 8.79 | 15.64 | 4.14 | 12.58 | 2.71 |
| Welcia Holdings Co Ltd | 1.22tn | 26.45bn | 479.06bn | 14.87k | 17.87 | 1.99 | 9.42 | 0.3935 | 127.85 | 127.85 | 5,879.06 | 1,150.65 | 2.24 | 6.37 | 20.73 | -- | 4.84 | 5.76 | 8.27 | 10.23 | 30.40 | 30.81 | 2.16 | 2.51 | 0.5507 | 44.99 | 0.2529 | 23.81 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
| Tsuruha Holdings Inc | 1.01tn | 27.10bn | 489.93bn | 11.30k | 17.84 | 1.70 | 10.33 | 0.4838 | 554.77 | 554.77 | 20,729.87 | 5,827.22 | 1.89 | 4.89 | 22.41 | 89,640,290.00 | 5.56 | 6.03 | 8.75 | 10.01 | 30.42 | 29.35 | 2.94 | 3.16 | 0.6803 | 38.96 | 0.1437 | 35.08 | 5.94 | 7.58 | 18.09 | 0.3683 | 21.98 | 12.23 |
| Sundrug Co Ltd | 736.88bn | 28.12bn | 536.87bn | 6.37k | 18.71 | 2.13 | 12.63 | 0.7286 | 240.46 | 240.46 | 6,301.25 | 2,109.59 | 2.02 | 6.33 | 28.21 | 115,661,800.00 | 7.70 | 8.25 | 11.25 | 12.02 | 25.35 | 24.81 | 3.82 | 3.85 | 0.9663 | -- | 0.00 | 35.78 | 6.43 | 4.12 | 7.76 | 0.6943 | 15.95 | 10.76 |
| Cosmos Pharmaceutical Corp | 936.71bn | 24.87bn | 588.01bn | 5.29k | 23.41 | 2.60 | 13.34 | 0.6277 | 627.89 | 627.89 | 23,646.83 | 5,659.54 | 2.32 | 9.86 | 2,065.50 | 177,071,100.00 | 6.16 | 7.02 | 10.96 | 13.37 | 19.65 | 20.03 | 2.66 | 3.18 | 0.1784 | 1,267.96 | 0.0456 | 12.24 | 9.57 | 8.21 | 2.77 | 6.18 | 9.63 | 17.32 |
| MatsukiyoCocokara & Co | 1.01tn | 50.58bn | 954.09bn | 13.66k | 18.40 | 1.84 | 13.26 | 0.9472 | 120.90 | 120.90 | 2,406.55 | 1,210.69 | 1.44 | 4.64 | 16.07 | 73,757,340.00 | 7.28 | 6.75 | 9.37 | 8.90 | 34.55 | 32.70 | 5.05 | 4.36 | 1.34 | -- | 0.0369 | 28.16 | 30.31 | 11.22 | 17.94 | 12.25 | 27.89 | 4.94 |
Data as of May 02 2024. Currency figures normalised to Cosmos Pharmaceutical Corp's reporting currency: Japanese Yen JPY
17.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 15 May 2023 | 2.02m | 5.04% |
| Fidelity Management & Research Co. LLCas of 13 Oct 2023 | 1.64m | 4.10% |
| Nomura Asset Management Co., Ltd.as of 29 Mar 2024 | 674.10k | 1.69% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 595.11k | 1.49% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 483.32k | 1.21% |
| BlackRock Investment Management LLCas of 25 Apr 2024 | 374.30k | 0.94% |
| JPMorgan Asset Management (Japan) Ltd.as of 31 Mar 2024 | 371.90k | 0.93% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 335.70k | 0.84% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 287.91k | 0.72% |
| Nikko Asset Management Co., Ltd.as of 05 Apr 2024 | 282.30k | 0.71% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
